Categories:

ANVISA – Questions & Answers on RDC 359/2020, which instituted DIFA and CADIFA for API used in the manufacture of Drug Products

On September 28th, ANVISA published the document Questions & Answers on RDC 359/2020, whi

On September 23, ANVISA published Service Orientation (OS) 90/2020, from the General Management of M

On July 29th, it was published on Brazilian Official Gazette (DOU) the RDC Nº 406/2020, regarding t

On June 3, two Public Consultations regarding the Simplified Notification of Low Risk Medicines were

On June 3, three Public Consultations regarding the Labeling of medicines were published in the Offi

On May 28, RDC 390/2020 was published in Brazilian Federal Register (D.O.U), which establishes rules

On May 20, ANVISA published the Public Consultation 812/2020, which proposes changes to RDC 73/16 re

On December 5, 2019, the Supreme Decree (SD) 026-2019-SA was published in the Official Gazette, whic

ANVISA informs that the Solicita System now allows third parties companies to make amendments of doc

The World Health Organization (WHO) has published a draft about health product traceability policies

Anvisa issues Service Orientation N°79/GGMED/DIRE2/ANVISA, of January 29, 2020 and one Information

On January 28, 2020, an Agreement from the Mexican Comisión Federal para la Protección Contra Ries